HomeNutritionThe Future Of The Diabetes Care Devices Market To 2016 - The Key Demand Drivers Remain Intact

The Future Of The Diabetes Care Devices Market To 2016 - The Key Demand Drivers Remain Intact

GBI Research’s new report, “The Future of the Diabetes Care Devices Market to 2016 – The Key Demand Drivers Remain Intact” provides key data, information and analysis on the global diabetes care devices market, a key segment within the medical equipment industry. This medical device report provides market landscape, competitive landscape and market trends information on two diabetes care devices market categories – glucose monitoring and insulin delivery. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope
• Key geographies including the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
• Global Market size and company share data for three diabetes care devices market categories – glucose monitoring and insulin delivery.
• Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
• Qualitative analysis of key market trends, market drivers and restraints by categories and segments.
• Competitive landscape and key company profiles. Key players covered include Roche, LifeScan, Bayer, Abbott, Becton, Dickinson, Medtronic, Novo Nordisk, Sanofi-Aventis, Eli Lilly, ARKRAY, Terumo, Animas and Smiths Medical.
• Key in-pipeline products and technologies expected to hit the global diabetes care devices market in the near future.

Reasons to buy
• Develop business strategies by understanding the trends and developments that are driving the diabetes care devices market globally.
• Design and develop your product development, marketing and sales strategies.
• Exploit M&A opportunities by identifying market players with the most innovative pipeline.
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
• What’s the next big thing in the diabetes care devices market landscape? – Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the diabetes care devices market and the factors shaping it.

1 Table of Contents

1.1 List of Tables 7
1.2 List of Figures 9

2 Introduction and Overview 11
2.1 Type 1 Diabetes 11
2.2 Type 2 Diabetes 11
2.3 Diabetes Accentuating Cardiovascular Disease 11
2.3.1 Atherosclerosis 11
2.3.2 Diabetic Cardiomyopathy 11
2.3.3 Stroke 11
2.3.4 Renal Disease 12
2.4 Diabetes a Burden on Healthcare Spending 12
2.5 Prevalence and Incidence of Diabetes 12
2.5.1 Global 12
2.5.2 Diabetes Prevalence in Developing Nations 13

3 Diabetes Care Devices Market: Market Characterization 14
3.1 Global Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 14
3.2 Global Diabetes Care Devices Market, Revenue Forecasts ($m), 2009 – 2016 15
3.3 Diabetes Care Devices, Key Market Trends 15
3.3.1 Home Healthcare Driving Growth in the Diabetes Care Devices Market 15
3.3.2 Brand Loyalty in Diabetes Care Devices: Hard To Achieve 16
3.3.3 Reimbursement Issues Restraining the Market 16
3.3.4 Drug Stores to Remain the Major Distribution Channels 16
3.4 Diabetes Care Devices: Technological Trends 17
3.4.1 Enhancing Life 17
3.4.2 Continuous Glucose Monitoring (CGM) 18
3.4.3 Disposable Insulin Pumps 18
3.4.4 Pain Free Monitoring Devices Will Drive Future Growth in the Diabetes Care Device Market 20
3.4.5 Increasing Demand for Pain Free Insulin Delivery Devices 21
3.4.6 Remote Monitoring: Increasing Diabetic Compliance 21
3.5 Diabetes Care Devices, Market Drivers 22
3.5.1 New Technologies to Boost Sales 22
3.5.2 Increasing Prevalence of Diabetes to Boost Sales 23
3.5.3 The Increasing Ageing Population of the World to Increase Patient Population 25
3.5.4 Introduction of New Generation Devices to Drive the Glucose Monitoring Market 25
3.5.5 Increase in Awareness of Better Diabetes Management 26
3.5.6 Lifestyle Changes Bringing About the Increase in Disease Prevalence 26
3.5.7 Product Innovation to Increase Acceptance 26
3.6 Restraints 26
3.6.1 Lack of Affordability and Awareness in Developing Nations 26
3.6.2 Lack of Reimbursement for New Technologies 26
3.6.3 Low diagnosis rate 26
3.6.4 Low Patient Compliance 27
3.6.5 Overall Cost Is a Restraint for Insulin Pens And Pumps 27
3.6.6 Other Factors Restraining the Diabetes Care Devices Market 27
3.6.7 Low Market Penetration Affecting Growth 27
3.7 Global Diabetes Care Devices Market, Key Company Shares (%), 2008 28

4 Global Diabetes Care Devices Market: Cross-Segment Market Analysis and Forecasts 29
4.1 Glucose Monitoring Market 29
4.1.1 Global Glucose Monitoring Market, Revenues ($m), 2002 – 2009 29
4.1.2 Global Glucose Monitoring Market, Revenue Forecasts ($m), 2009 – 2016 30
4.1.3 Market Drivers 30
4.1.4 Market Restraints 31
4.1.5 Glucose Monitoring Market, Revenue by Segment 32
4.1.6 Blood Glucose Meters Market Dynamics 33
4.1.7 Blood Glucose Test Strips Market Revenue 34
4.1.8 Blood Glucose Test Strips Market Dynamics 35
4.2 Insulin Delivery Devices 36
4.2.1 Global Insulin Delivery, Revenue ($m), Global, 2002 – 2009 37
4.2.2 Global Insulin Delivery, Revenue ($m), Global, 2009 – 2016 38
4.2.3 Market Drivers 38
4.2.4 Market Restraints 39
4.2.5 Insulin Pumps Market Revenue 40
4.2.6 Insulin Pumps, Revenue ($m), Global, Forecast 41
4.2.7 Insulin Pumps Market Dynamics 41
4.2.8 Insulin Pens Market Revenue 42
4.2.9 Insulin Pens Market Dynamics 44
4.2.10 Insulin Syringes, Market Revenue 44
4.2.11 Insulin Syringes Market Dynamics 45

5 Diabetes Care Devices: Competitive Landscape 46
5.1 Insulin Delivery Competitive Landscape 46
5.1.1 Strategic Competitor Assessment 46
5.1.2 Insulin Delivery Devices, Company Share Analysis (%), 2008 47
5.2 Key Companies 47
5.2.1 Becton, Dickinson and Company 47
5.2.2 Medtronic 47
5.2.3 Novo Nordisk 47
5.2.4 Others 48
5.2.5 Insulet Corporation 48
5.2.6 NiliMEDIX 48
5.2.7 Medingo Ltd. 48
5.2.8 Debiotech S.A 48
5.2.9 Phluid Corporation 48
5.2.10 Ratio Inc. 48
5.2.11 Insuline Medical Ltd. 48
5.2.12 Aradigm Corporation 48
5.2.13 MannKind Corporation 49
5.2.14 Altea Therapeutics Corporation 49
5.3 Glucose Monitoring Systems Market : Competitive Assessment 49
5.3.1 Overview 49
5.3.2 Strategic Competitor Assessment 49
5.3.3 Glucose Monitoring Systems Company Shares 2008 50
5.3.4 F. Hoffmann-La Roche Ltd 50
5.3.5 LifeScan (Johnson & Johnson) 51
5.3.6 Bayer Healthcare 51
5.3.7 Abbott Laboratories 51
5.3.8 Product Profiles of the Major Marketed Products in the Glucose Monitoring Systems Market 52
5.3.9 OneTouch UltraMini 53
5.3.10 Contour Meter 54

6 Global Diabetes Care Devices Market: Cross-Country Analysis and Forecasts 55
6.1 Revenues, By Country, 2002 – 2009 55
6.1.1 The US Diabetes Care Devices Market, Revenue ($m), 2002 – 2009 55
6.1.2 Canada Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 56
6.1.3 The UK Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 57
6.1.4 Germany Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 58
6.1.5 France Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 59
6.1.6 Italy Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 60
6.1.7 Spain Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 61
6.1.8 Japan Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 62
6.1.9 China Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 63
6.1.10 India Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 64
6.1.11 Australia Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 65
6.1.12 Brazil Diabetes Care Devices Market, Revenues ($m), 2002 – 2009 66
6.2 Revenue Forecasts, By Country, 2009 – 2016 67
6.2.1 The US Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 67
6.2.2 Canada Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 68
6.2.3 The UK Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 69
6.2.4 Germany Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 70
6.2.5 France Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 71
6.2.6 Italy Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 72
6.2.7 Spain Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 73
6.2.8 Japan Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 74
6.2.9 China Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 75
6.2.10 India Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 76
6.2.11 Australia Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 77
6.2.12 Brazil Diabetes Care Devices Market, Revenues ($m), 2009 – 2016 78

7 Diabetes Care Devices: Pipeline Analysis 79
7.1 Glucose Monitoring Key Pipeline Products 79
7.1.1 Strategic Pipeline Assessment 79
7.1.2 Glucose Monitoring Systems – Pipeline by Clinical Phase of Development 80
7.1.3 Profiles of Promising Devices under Clinical Development 80
7.1.4 Glucose Monitoring Systems Market: List of Pipeline Products 83
7.1.5 Glucose Monitoring Systems Pipeline Product Summary by Product Type 86
7.1.6 Glucose Monitoring Systems Pipeline Product Summary: Home Glucose Monitoring Systems 87
7.1.7 Glucose Monitoring Systems Pipeline Product Summary: Hospital Setting Glucose Monitoring Systems 89
7.1.8 Glucose Monitoring Systems Pipeline Product Summary: Both Home and Hospital Setting Glucose Monitoring Systems 89
7.2 Implications for Future Market Competition 90
7.3 Strategic Competitor Assessment 90
7.4 Glucose Monitoring Systems Market: Emerging Companies 91
7.4.1 Introduction 91
7.5 Insulin Delivery Key Pipeline Products 92
7.5.1 Overview 92
7.5.2 Strategic Pipeline Assessment 93
7.5.3 Insulin Delivery Devices – Clinical Pipeline by Mode of Insulin Delivery 94
7.6 Insulin Delivery Devices – Pipeline by Clinical Phase of Development 95
7.7 Insulin Delivery Devices Pipeline Product Summary 96
7.8 Insulin Delivery Devices – Promising Devices under Clinical Development 96
7.8.1 Closed-loop diabetes management system 96
7.8.2 Paradigm Veo System 97
7.8.3 AERx insulin Diabetes Management System 98
7.8.4 Insulin Delivery Devices – Future Market Competition 102
7.8.5 Strategic Competitor Assessment 102
7.9 Reimbursement for Insulin Delivery Devices 103

8 Global Diabetes Care Devices Market: Consolidation Landscape 105
8.1 Deal Analysis-Q1 2009 105
8.1.1 Diabetes Care Devices- Deals of Quarter 1 106
8.2 Deal Analysis Q2 2009 106
8.2.1 Diabetes Care Devices – Deals of Quarter 2 107
8.3 Deal Analysis Q3 2009 108
8.3.1 Diabetes Care Devices – Deals of the Quarter 3 109
8.4 Deal Analysis – October 2009 109
8.5 Deal Analysis – December 2009 110

9 Appendix 112
9.1 Decision Support Database 112
9.1.1 Complications with Diabetes 112
9.2 Diabetes Care Devices: Definitions 113
9.2.1 Glucose Monitoring 113
9.2.2 Insulin Delivery 113
9.3 Methodology 113
9.3.1 Secondary Research 114

9.3.2 Primary Research 114
9.3.3 Models 115
9.3.4 Forecasts 115
9.3.5 Expert Panels 115
9.4 Contact Us 115
9.5 Disclaimer 116

1.1 List of Tables
Table 1: Diabetes Mellitus, Estimated Patient Population (‘000’s), 2030 13
Table 2: Diabetes Care Devices, Revenue ($m), Global, 2002 – 2009 14
Table 3: Diabetes Care Devices, Revenue ($m), Global, 2009 – 2016 15
Table 4: Total Cost, Traditional Glucose Meter Vs Continuous Glucose Monitor 16
Table 5: Disposable Insulin Pumps, Revenue ($m), US, 2005 – 2009 19
Table 6: Disposable Insulin Pumps, Revenue ($m), US, 2009 – 2015 20
Table 7: Non Invasive Glucose Monitoring Products 21
Table 8: Pain Free Insulin Delivery Products, 2009 21
Table 9: Prevalence Estimates of Diabetes, Global, 2030 23
Table 10: Prevalence of Diabetes (Diagnosed And Undiagnosed), By Age Group, US, 2007 24
Table 11: Prevalence of Diabetes (Diagnosed And Undiagnosed), By Gender, US, 2007 25
Table 12: Population Over the age of 65 (‘000’s), 2005 – 2010 25
Table 13: Glucose Monitoring, Revenue ($m), Global, 2002 – 2009 29
Table 14: Glucose Monitoring, Revenue ($m), Global, 2009 – 2016 30
Table 15: Blood Glucose Meters, Revenue ($m), Global, 2000 – 2009 32
Table 16: Blood Glucose Meters, Revenue ($m), Global, 2009 – 2016 33
Table 17: Blood Glucose Test Strips, Revenue ($m), Global, 2002 – 2009 34
Table 18: Blood Glucose Test Strips, Revenue ($m), Global, 2009 – 2016 35
Table 19: Comparison of Insulin Delivery Devices 36
Table 20: Insulin Delivery, Revenue ($m), Global, 2002 – 2009 37
Table 21: Insulin Delivery, Revenue ($m), Global, 2009 – 2016 38
Table 22: Insulin Pumps, Revenue ($m), Global, 2002 – 2009 40
Table 23: Insulin Pumps, Revenue ($m), Global, 2009 – 2016 41
Table 24: Insulin Pens, Revenue ($m), Global, 2002 – 2009 43
Table 25: Insulin Pens, Revenue ($m), Global, 2009 – 2016 43
Table 26: Insulin Syringes, Revenue ($m), Global 2002 – 2009 44
Table 27: Insulin Syringes, Revenue ($m), Global 2009 – 2016 45
Table 28: Diabetes Care Devices Market, Revenue ($m), US, 2002 – 2009 55
Table 29: Diabetes Care Devices Market, Revenue ($m), Canada, 2002 – 2009 56
Table 30: Diabetes Care Devices Market, Revenue ($m), UK, 2002 – 2009 57
Table 31: Diabetes Care Devices Market, Revenue ($m), Germany, 2002 – 2009 58
Table 32: Diabetes Care Devices Market, Revenue ($m), France, 2002 – 2009 59
Table 33: Diabetes Care Devices Market, Revenue ($m), Italy, 2002 – 2009 60
Table 34: Diabetes Care Devices Market, Revenue ($m), Spain, 2002 – 2009 61
Table 35: Diabetes Care Devices Market, Revenue ($m), Japan, 2002 – 2009 62
Table 36: Diabetes Care Devices Market, Revenue ($m), China, 2002 – 2009 63
Table 37: Diabetes Care Devices Market, Revenue ($m), India, 2002 – 2009 64
Table 38: Diabetes Care Devices Market, Revenue ($m), Australia, 2002 – 2009 65
Table 39: Diabetes Care Devices Market, Revenue ($m), Brazil, 2002 – 2009 66
Table 40: Diabetes Care Devices Market, Revenue ($m), US, 2009 – 2016 67
Table 41: Diabetes Care Devices Market, Revenue ($m), Canada, 2009 – 2016 68
Table 42: Diabetes Care Devices Market, Revenue ($m), UK, 2009 – 2016 69
Table 43: Diabetes Care Devices Market, Revenue ($m), Germany, 2009 – 2016 70
Table 44: Diabetes Care Devices Market, Revenue ($m), France, 2009 – 2016 71
Table 45: Diabetes Care Devices Market, Revenue ($m), Italy, 2009 – 2016 72
Table 46: Diabetes Care Devices Market, Revenue ($m), Spain, 2009 – 2016 73
Table 47: Diabetes Care Devices Market, Revenue ($m), Japan, 2009 – 2016 74
Table 48: Diabetes Care Devices Market, Revenue ($m), China, 2009 – 2016 75
Table 49: Diabetes Care Devices Market, Revenue ($m), India, 2009 – 2016 76
Table 50: Diabetes Care Devices Market, Revenue ($m), Australia, 2009 – 2016 77
Table 51: Diabetes Care Devices Market, Revenue ($m), Brazil, 2009 – 2016 78
Table 52: Glucose Monitoring Systems Pipeline Product Summary – I 83
Table 53: Glucose Monitoring Systems Pipeline Product Summary – II 84
Table 54: Glucose Monitoring Systems Pipeline Product Summary – III 85
Table 55: Home Glucose Monitoring Systems Pipeline Product Summary – I 87
Table 56: Home Glucose Monitoring Systems Pipeline Product Summary – II 88
Table 57: Hospital Setting Glucose Monitoring System Pipeline Product Summary 89
Table 58: Home and Hospital Setting Glucose Monitoring Systems Pipeline Product Summary 89
Table 59: Glucose Monitoring Systems Emerging Companies and Products- I 91
Table 60: Glucose Monitoring Systems Emerging Companies and Products – II 92
Table 61: Global Insulin Delivery Devices Pipeline Product Summary 96
Table 62: Closed-loop diabetes management system, Product Status 96
Table 63: Closed-loop diabetes management system, Product Description 97
Table 64: Paradigm Veo System, Product Status 97
Table 65: Paradigm Veo System, Product Description 97
Table 66: AERx insulin Diabetes Management System, Product Status 98
Table 67: AERx insulin Diabetes Management System, Product Description 98
Table 68: AERx insulin Diabetes Management System – Effect of Inhaled Insulin (AERx   iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes 99
Table 69: AERx insulin Diabetes Management System – Inhaled Pre-Prandial Human Insulin With the AERx iDMS Versus s.c. Insulin Aspart in Type 2 Diabetes: A 104 Week, Open-Label, Multicenter, Randomized, Trial Followed by a 12 Week re-Randomized Extension to Investigate Safety and Efficacy 100
Table 70: AERx insulin Diabetes Management System – Inhaled Mealtime Insulin With the AERx iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomized, Parallel Trial (Followed by a Twelve-Week Re-Randomized Extension) To Investigate Safety and Efficacy 101
Table 71:  Medical Equipment, Diabetes Care Devices, Deals Summary, Q2 2008 – Q1 2009 105
Table 72:  Medical Equipment, Diabetes Care Devices, Deals Summary, Q2 2008 – Q2 2009 107
Table 73:  Medical Equipment, Diabetes Care Devices, Deals Summary, Q3 2008 – Q3 2009 108
Table 74:  Medical Equipment, Diabetes Care Devices, Deals Summary, April 2009 – September 2009 109
Table 75:  Medical Equipment, Diabetes Care Devices, Deals Summary, May 2009 – October 2009 110
Table 76:  Medical Equipment, Diabetes Care Devices, Deals Summary, June 2009 – November 2009 111
Table 77: Prevalence of Diabetes (Diagnosed And Undiagnosed), By Age Group, US, 2007 112

1.2 List of Figures
Figure 1: Diabetes Care Devices, Revenue ($m), Global, 2002 – 2009 14
Figure 2: Diabetes Care Devices, Revenue ($m), Global, 2009 – 2016 15
Figure 3: Glucose Monitoring Devices, Distribution Channel Shares (%), 2008 17
Figure 4: Insulin Delivery, Distribution Channel Shares (%), 2008 17
Figure 5: Disposable Insulin Pumps, Revenue ($m), US, 2005 – 2009 19
Figure 6: Disposable Insulin Pumps, Revenue ($m), US, 2009 – 2015 20
Figure 7: Diabetes Incidence by Diagnosis, US, 2007 24
Figure 8: Diabetic Population by Treatment Type, US, 2007 24
Figure 9: Diabetes Care Devices, Company Share (%), Global, 2008 28
Figure 10: Glucose Monitoring, Revenue ($m), Global, 2002 – 2009 29
Figure 11: Glucose Monitoring, Revenue ($m), Global, 2009 – 2016 30
Figure 12: Blood Glucose Meters, Revenue ($m), Global, 2000 – 2009 32
Figure 13: Blood Glucose Meters, Revenue ($m), Global, 2009 – 2016 33
Figure 14: Blood Glucose Test Strips, Revenue ($m), Global, 2002 – 2009 34
Figure 15: Blood Glucose Test Strips, Revenue ($m), Global, 2009 – 2016 35
Figure 16: Insulin Delivery, Revenue ($m), Global, 2002 – 2009 37
Figure 17: Insulin Delivery, Revenue ($m), Global, 2009 – 2016 38
Figure 18: Insulin Pumps, Revenue ($m), Global, 2002 – 2009 40
Figure 19: Insulin Pumps, Revenue ($m), Global, 2009 – 2016 41
Figure 20: Insulin Pens, Revenue ($m), Global, 2002 – 2009 42
Figure 21: Insulin Pens, Revenue ($m), Global, 2009 – 2016 43
Figure 22: Insulin Syringes, Revenue ($m), Global 2002 – 2009 44
Figure 23: Insulin Syringes, Revenue ($m), Global 2009 – 2016 45
Figure 24: Strategic Competitive Assessment 46
Figure 25: Insulin Delivery Devices, Company Share Analysis (%), 2008 47
Figure 26: Glucose Monitoring, Strategic Competitive Assessment 49
Figure 27: Glucose Monitoring Systems, Company Shares – 2008 50
Figure 28: Diabetes Care Devices Market, Revenue ($m), US, 2002 – 2009 55
Figure 29: Diabetes Care Devices Market, Revenue ($m), Canada, 2002 – 2009 56
Figure 30: Diabetes Care Devices Market, Revenue ($m), UK, 2002 – 2009 57
Figure 31: Diabetes Care Devices Market, Revenue ($m), Germany, 2002 – 2009 58
Figure 32: Diabetes Care Devices Market, Revenue ($m), France, 2002 – 2009 59
Figure 33: Diabetes Care Devices Market, Revenue ($m), Italy, 2002 – 2009 60
Figure 34: Diabetes Care Devices Market, Revenue ($m), Spain, 2002 – 2009 61
Figure 35: Diabetes Care Devices Market, Revenue ($m), Japan, 2002 – 2009 62
Figure 36: Diabetes Care Devices Market, Revenue ($m), China, 2002 – 2009 63
Figure 37: Diabetes Care Devices Market, Revenue ($m), India, 2002 – 2009 64
Figure 38: Diabetes Care Devices Market, Revenue ($m), Australia, 2002 – 2009 65
Figure 39: Diabetes Care Devices Market, Revenue ($m), Brazil, 2002 – 2009 66
Figure 40: Diabetes Care Devices Market, Revenue ($m), US, 2009 – 2016 67
Figure 41: Diabetes Care Devices Market, Revenue ($m), Canada, 2009 – 2016 68
Figure 42: Diabetes Care Devices Market, Revenue ($m), UK, 2009 – 2016 69
Figure 43: Diabetes Care 0044evices Market, Revenue ($m), Germany, 2009 – 2016 70
Figure 44: Diabetes Care Devices Market, Revenue ($m), France, 2009 – 2016 71
Figure 45: Diabetes Care Devices Market, Revenue ($m), Italy, 2009 – 2016 72
Figure 46: Diabetes Care Devices Market, Revenue ($m), Spain, 2009 – 2016 73
Figure 47: Diabetes Care Devices Market, Revenue ($m), Japan, 2009 – 2016 74
Figure 48: Diabetes Care Devices Market, Revenue ($m), China, 2009 – 2016 75
Figure 49: Diabetes Care Devices Market, Revenue ($m), India, 2009 – 2016 76
Figure 50: Diabetes Care Devices Market, Revenue ($m), Australia, 2009 – 2016 77
Figure 51: Diabetes Care Devices Market, Revenue ($m), Brazil, 2009 – 2016 78
Figure 52: Technology Trends Analytic Framework 79
Figure 53: Glucose Monitoring Systems – Pipeline by Clinical Phase of Development 80
Figure 54: Glucose Monitoring Systems Pipeline Product by Product Type 86
Figure 55: Strategic Competitor Assessment 90
Figure 56: Technology Trends Analytic Framework 93
Figure 57: Technology Trends Analytic Framework – Descriptions 94
Figure 58: Insulin Delivery Devices – Clinical Pipeline by Mode of Insulin Delivery 94
Figure 59: Insulin Delivery Devices Pipeline by Clinical Phase of Development 95
Figure 60: Strategic Competitor Assessment 102
Figure 61: Reimbursement for Insulin Delivery Devices 103
Figure 62: Reimbursement Mix – Insulin Pens 104
Figure 63: Medical Equipment, Diabetes Care Devices, Deal Value and Volume, Q2 2008 – Q1 2009 105
Figure 64: Medical Equipment, Diabetes Care Devices, Deal Value and Volume, Q2 2008 – Q2 2009 106
Figure 65: Medical Equipment, Diabetes Care Devices, Deal Value and No. Of Deals, Q3 2008 – Q3 2009 108
Figure 66: Diabetes Incidence by Diagnosis, US, 2007 112
Figure 67: Diabetic Population by Treatment Type, US, 2007 112
Figure 68: GBI Research Methodology 114


Source by Reports

Previous post
Herbs for Diabetes Can Herbal Supplements Lower Blood Sugar
Next post
Dr. Draluck, D.C.: About Diabetes

Leave a Reply

Be the First to Comment!

Notify of
avatar
wpDiscuz